Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by threefiftynineon Jun 17, 2020 11:58am
99 Views
Post# 31160472

RE:RE:Just look at the chart !!!

RE:RE:Just look at the chart !!!
what the poster is saying indirectly is that the company were responsible through shorting for the stock to dive after really upbeat news releases that have basically dried up and have enabled a private placement of .085 to take place . if the private placement closes at full capacity and a vast majority is insider based and subsequently ground breaking news is released then shareholders not participating in the PP have every right to be ticked off---as it will then look like it was an orchestrated shorting of the stock---We will find out shortly if the ceo making this statement "IF WE ARE SUCCESSFULL IN PROVING THE SAFETY OF OUR COVID19 VACCINE IN PHASE1" is nothing more than a BLOWHARD choice of words . If indeed that's the case then the PP is only worth .085 cents----and the ceo has indeed uttered a false and misleading statement---IF, is a fascinating word.----"IF" only the TSXV clamped down on shorting for greedy investors and company's to take advantage of.
<< Previous
Bullboard Posts
Next >>